Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
32.20
+0.22 (0.69%)
Nov 22, 2024, 4:00 PM EST - Market closed
Edgewise Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -124.29 | -100.16 | -67.64 | -42.81 | -17.12 | -9.71 |
| Depreciation & Amortization | 2.19 | 1.73 | 0.54 | 0.27 | 0.19 | 0.12 |
| Loss (Gain) From Sale of Investments | -12.12 | -9.52 | -0.54 | - | - | - |
| Stock-Based Compensation | 22.13 | 17.56 | 10.92 | 4.4 | 0.35 | 0.08 |
| Change in Accounts Payable | 0.26 | -0.09 | 0.05 | 2.65 | 0.52 | 0.28 |
| Change in Other Net Operating Assets | 2.92 | -1.47 | 4.04 | 1.98 | 1.43 | 0.06 |
| Operating Cash Flow | -108.9 | -91.95 | -52.64 | -33.51 | -14.63 | -9.17 |
| Capital Expenditures | -1.2 | -5.75 | -5.55 | -0.67 | -0.2 | -0.18 |
| Investment in Securities | -177.4 | 108.63 | -65.03 | -241.56 | -24.18 | - |
| Investing Cash Flow | -178.6 | 102.89 | -70.58 | -242.23 | -24.38 | -0.18 |
| Issuance of Common Stock | 299.56 | 53.33 | 129.89 | 186.51 | 0.2 | 0.02 |
| Other Financing Activities | -0.21 | -0.17 | -0.25 | -0.12 | - | -0.3 |
| Financing Cash Flow | 299.35 | 53.17 | 129.64 | 186.38 | 120.28 | 24.8 |
| Net Cash Flow | 11.85 | 64.1 | 6.43 | -89.35 | 81.26 | 15.45 |
| Free Cash Flow | -110.1 | -97.69 | -58.18 | -34.18 | -14.84 | -9.35 |
| Free Cash Flow Per Share | -1.30 | -1.53 | -1.09 | -0.91 | -20.08 | -24.75 |
| Levered Free Cash Flow | -64.97 | -61.66 | -35.48 | -19.26 | -7.36 | - |
| Unlevered Free Cash Flow | -64.97 | -61.66 | -35.48 | -19.26 | -7.36 | - |
| Change in Net Working Capital | -3.88 | 3.74 | -3.39 | -3.75 | -3.05 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.